Metabolic fingerprinting of fresh lymphoma samples used to discriminate between follicular and diffuse large B-cell lymphomas

Experimental Hematology

Volumn 37, Issue 11, 2009, Pages 1259-1265

  Barba, Ignasi ^a   Sanz, Carolina ^b   Barbera, Angels ^b   Tapia, Gustavo ^b   Mate, José Luis ^b   Garcia Dorado, David ^a   Ribera, Josep Maria ^b   Oriol, Albert ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; KI 67 ANTIGEN; TAURINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; MALE; METABOLITE; NON INVASIVE MEASUREMENT; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; TISSUE LEVEL;

AGED; ALANINE; ANTIGENS, CD; ANTIGENS, NEOPLASM; CREATINE; FEMALE; GLUTAMIC ACID; HUMANS; IMMUNOPHENOTYPING; KI-67 ANTIGEN; LYMPH NODES; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TAURINE;

EID: 70349981334     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.08.006     Document Type: Article

References (33)

1. de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 23 (2005) 6358-6363
2. Lossos I.S. Molecular pathogenesis of diffuse large B-cell lymphoma. J Clin Oncol 23 (2005) 6351-6357
3. Armitage J.O., Bierman P.J., Bociek R.G., and Vose J.M. Lymphoma 2006: classification and treatment. Oncology 20 (2006) 231-239
4. Griffin J.L., and Kauppinen R.A. Tumour metabolomics in animal models of human cancer. J Proteom Res 6 (2007) 498-505
5. Preul M.C., Caramanos Z., Collins D.L., et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2 (1996) 323-325
6. García-Gómez J.M., Tortajada S., Vidal C., et al. The effect of combining two echo times in automatic brain tumor classification by MRS. NMR Biomed 21 (2008) 1112-1125
7. Poullet J.B., Martinez-Bisbal M.C., Valverde D., et al. Quantification and classification of high-resolution magic angle spinning data for brain tumor diagnosis. Conf Proc IEEE Eng Med Biol Soc (2007) 5407-5410
8. Zacharia T.T., Law M., Naidich T.P., and Leeds N.E. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging 18 (2008) 411-417
9. Ellis D.I., Dunn W.B., Griffin J.L., Allwood J.W., and Roodacre R. Metabolic fingerprinting as diagnostic tool. Pharmacogenomics 8 (2007) 1243-1266
10. Kell D.B. Systems biology, metabolic modeling and metabolomics in drug discovery and development. Drug Discov Today 11 (2006) 1085-1092
11. Clayton T.A., Lindon J.C., Cloarec O., et al. Pharmaco-metabolomic phenotyping and personalized drug treatment. Nature 440 (2006) 1073-1077
12. Swerdlow S.H., Campo E., Harris N.L., et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. (2008), International Agency for Research on Cancer, Lyon, France
13. Barba I., Jaimez-Auguets E., Rodriguez-Sinovas A., and Garcia-Dorado D. 1H NMR-based metabolomic identification of at-risk areas after myocardial infarction in swine. MAGMA 20 (2007) 265-271
14. Barba I., Chatauret N., García-Dorado D., and Córdoba J. A 1H nuclear magnetic resonance-based metabolomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int 28 (2008) 1141-1148
15. Barba I., de León G., Martín E., et al. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 60 (2008) 27-32
16. Wold S., Antti H., Lindgren F., and Ohman J. Orthogonal signal correction of near-infrared spectra. Chemometrics Intel Lab Syst 44 (1998) 175-185
17. Dieterle F., Ross A., Schlotterbeck G., and Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 78 (2006) 4281-4290
18. Tang B., Malysz J., Douglas-Nikitin V., et al. Correlating metabolic activity with cellular proliferation in follicular lymphomas. Mol Imaging Biol 11 (2009) 296-302
19. Monti S., Savage K.J., Kutok J.L., et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105 (2005) 1851-1861
20. Juweid M.E., Stroobants S., Hoekstra O.S., et al. Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25 (2007) 571-578
21. Husson H., Carideo E.G., Neuberg D., et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 99 (2002) 282-289
22. Hans C.P., Weisenburger D.D., Greiner T.C., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (2004) 275-282
23. Hoh C.K., Glaspy J., Rosen P., et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 38 (1997) 343-348
24. El-Sayed S., Bezabeh T., Odlum O., et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck 24 (2002) 766-772
25. Moreno A., Lopez L.A., Fabra A., and Arús C. 1H MRS markers of tumour growth in intrasplenic tumours and liver metastasis induced by injection of HT-29 cells in nude mice spleen. NMR Biomed 11 (1998) 93-106
26. ter Kuile B.H., and Westerhoff H.V. Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway. FEBS Lett 500 (2001) 169-171
27. Raamsdonk L.M., Teusink B., Broadhurst D., et al. Functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19 (2001) 45-50
28. Griffin J.L. Metabolomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr Opin Chem Biol 7 (2003) 648-654
29. Pfeuffer J., Tkác I., Provencher S.W., and Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson 141 (1999) 104-120
30. Day S.E., Kettunen M.I., Gallagher F.A., et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 13 (2007) 1382-1387
31. Lee S.C., Huang M.Q., Nelson D.S., et al. In vivo MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft. NMR Biomed 21 (2008) 723-733
32. Huang M.Q., Nelson D.S., Pickup S., et al. In vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRS. Acad Radiol 14 (2007) 1531-1539
33. Lee S.C., Delikatny E.J., Poptani H., Pickup S., and Glickson J.D. In vivo (1)H MRS of WSU-DLCL2 human non-Hodgkin's lymphoma xenografts: response to rituximab and rituximab plus CHOP. NMR Biomed 22 (2009) 259-265